Regencell Bioscience Holdings (RGC) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	186.9M
Trade and other receivables	45M
Income tax receivable	0
Inventories	20.5M
Prepaid expenses and other current assets	29.4M
Assets held for sale
Deferred income tax asset
TOTAL CURRENT ASSETS	282.8M
Land	131.2M
Buildings and leasehold improvements	2.28B
Equipment	1.1B
Construction in progress	15.5M
Total property and equipment	3.52B
Accumulated depreciation and amortization	-2.14B
TOTAL PROPERTY AND EQUIPMENT, NET	1.38B
GOODWILL	328.7M
INTANGIBLE ASSETS, NET	47M
DEFERRED INCOME TAX ASSET
OTHER NON-CURRENT ASSETS	374.3M
TOTAL ASSETS	2.48B
Current portion of debt obligations	25.1M
Accounts payable	101.5M
Accrued expenses	76.2M
Deferred revenue	156.9M
Interest payable	8.9M
TOTAL CURRENT LIABILITIES	371.8M
LONG-TERM DEBT, LESS CURRENT PORTION	2.2B
LEASE FINANCING ARRANGEMENTS, LESS CURRENT PORTION	88M
CAPITAL LEASE OBLIGATIONS, LESS CURRENT PORTION	7.5M
NON-CURRENT DEFERRED REVENUE	415.4M
OTHER NON-CURRENT LIABILITIES	259.7M
TOTAL LIABILITIES	3.34B
DEFICIT:
Preferred stock, $0.001 par value; 50,000,000 shares authorized; none issued and outstanding	0
Additional paid-in capital (deficit)	-936.5M
Retained earnings	77.4M
Accumulated other comprehensive loss, net	-2.7M
TOTAL STOCKHOLDERS' DEFICIT OF REGAL ENTERTAINMENT GROUP	-861.7M
Noncontrolling interest	200K
TOTAL DEFICIT	-861.5M
TOTAL LIABILITIES AND DEFICIT	2.48B
DEFICIT:
Common stock	100K
DEFICIT:
Common stock	0

Entities mentioned with RGC

View All Entities